Infectious Diseases

Dr. Samar Assem Badreddine

Contact Info

+971 4 41 44444

Designation: Consultant Infectious Diseases
Specialty: Infectious Diseases
Languages: English, French and Arabic

Core Competencies

  • Managing fever
  • Treating community acquired infections (viral, bacterial, fungal and tropical illnesses)
  • Sexually transmitted diseases
  • Infections in immunosuppressed patients (patients on chemotherapy, biologic agents, post-transplant and patients with HIV)

Brief Profile

Dr. Samar Assem Badreddine has joined Dubai Silicon Oasis’ Fakeeh University Hospital, after being an Infectious Diseases Consultant and the Director of the Infection Control Department at Dr. Soliman Fakeeh Hospital (DSFH) in Jeddah, Saudi Arabia. She was also the Chief of Medical & Clinical Division at DSFH.

Prior to this, from 2001 till 2009 Dr. Badreddine was the Consultant of Infectious Diseases and Director of Infection Control at King Faisal Specialist Hospital and Research Centre, Jeddah. She then moved to Dubai in 2009 and till 2011, she served as a Consultant in Infectious Diseases and Director of the Infection Control Department at Dubai Health Authority’s Rashid Hospital. She then went back to Saudi Arabia and joined DSFH.

In her illustrious career of 25 years, she has been a recipient of many recognitions, like the Arab Health Award for Infection Control in 2009 and Team Leader of Infection Control Chapter, Mecca Region Quality Program, 2002-2006.

She has been a member of:

  • American Board of Internal Medicine,1994
  • American Board of Infectious Diseases,1996

Qualifications

  • Doctor of Medicine Degree, Faculty of Medicine, American University of Beirut, Beirut, 1989
  • American Board Certified in Internal Medicine, Wayne State University, Michigan, USA, 1994
  • American Board Certified in Infectious Diseases, Wayne State University, Michigan, USA, 1996

Research & Publications

  • 2020: Badreddine S, et al “Clinical course and outcome of 395 Covid 19 patients admitted to one hospital in Jeddah- Saudi Arabia”. IJIDT 2020; 5(4): 118-126
  • 2017: Rodgers MA, Vallari A, Yamaguchi J, Holzmayer V, Harris B, Badreddine S, Cloherty G. “ Architect Combo HIV Ab/Ab and Real time HIV-1 assays detect diverse HIV strains in clinical specimen . AIDS Res Hum Retroviruses  
  • 2017: Badreddine S, et al “Dengue fever: clinical features of 567 consecutive patients admitted to a tertiary care center in Saudi Arabia”. Saudi Med J 2017; Vol. 38(10): 1025
  • 2017: Badreddine S, Al Amoudi A, AbdelRauf B, Al-Katheeri A, Almutawa A, Al-   Ghamdi SMG. “Verticillium Species Skin Infection in a Renal Transplant Patient”. Exp Clin Transplant. 2017 May 22. doi: 10.6002/ ect. 2016.0144
  • 2016: Abro AH, Rahimi MR, Jasim LM, Badreddine S, AlDeesi Z.“Sphingobacterium multivorum Bacteremia and Acute Meningitis in an Immunocompetent Adult Patient: A Case Report”.
  • 2016: Al-Ammari,M, Badreddine S, Almoallim,H. “A case of Bacterium Riyadhensis in a patient with AIDS”. Case reports in infectious diseases, Vol 2016, article ID 5908096. http://dx.doi.org/10.1155/2016/5908096           
  • 2014: Mimesh Z, Tokars J, Badreddine S. “Healthcare Workers contact with MERS patient, SA”. EID, Dec 2014, Vol 12, No 12                                   
  • 2011: Al-Dabal l, Badreddine S, Abro A. “Prevalence and pattern of pulmonary infection among HIV/AIDS adult patients admitted to a tertiary care hospital, Dubai, United Arab Emirates, 2009-2010”. Poster at the European respiratory society, 2011
  • 2008: Yamaguchi, J, Badreddine S, et al. (2008). “Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates.” AIDS Res Hum Retroviruses   24 (10): 1327-35.
  • 2007: Badreddine S, et al. “Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found”. AIDS Res Hum Retroviruses. 2007 May; 23(5):667-74.
  • 2007: Julie Yamaguchi, Samar Badreddine, Priscilla Swanson, Pierre Bodelle, Sushil G. Devare, Catherine A. Brennan. “Identification of a novel CRF and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV- 1 isolates”. Poster presentation at the 15 th Conference on   Retroviruses and Opportunistic Infections (CROI) .February 2008, Boston, MA   
  • 2007: Khalil-ur-Rahman1, Al-Amoudi A, Badreddine S, Al-Shehri AM, Kanaan H, Al-Ghamdi SM. “Cryptosporidiosis in a renal transplant patient treated with paromomycin”. Ann Saudi Med. 2007 Sep-Oct; 27(5):373-4.  
  • 2000: Patterns of use of antibiotics among Lebanese citizens in City of Saida. Lebanese University. (Badreddine S, Primary Investigator)
  • 1999: Changing patterns of resistance of Pseudomonas Aerogenosa in the city of Saida from 1993-1998. Lebanese University. (Badreddine S, Primary investigator)
  • 1996: Fairfax M , Badreddine S. Mycobacterium Growth Indicator Tube: a new culture medium for mycobacteria. American society of microbiology meeting, New Orleans, USA, abstract
  • 1996: Cryptococcal disease in HIV positive patients. Detroit Medical Center experience. (Vasquez J, Primary investigator)
  • 1995: Badreddine S, Crane L. “Mycobacteruim Kansasii brain Abscess In AIDS patient”. American college of physician meeting, Michigan, USA-Abstract

Nationality: Lebanese

Number of Years of Experience: 25 years